Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2025-12-26 @ 6:27 PM
Study NCT ID:
NCT06675032
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-11-05
First Post:
2024-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years
Sponsor:
Shanghai Reinovax Biologics Co.,LTD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-27
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-04
First Submit QC Date:
None
Study First Post Date:
2024-11-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-04
Last Update Post Date:
2024-11-05
Last Update Post Date Type:
ACTUAL